Archives: Speakers

20+ years of experience in drug discovery and clinical development including management of phase I, II, and III studies.

Expertise in Early Development including developing strategy for 15+ IND/FIH submissions. Developed strategy for execution of over 200 clinical pharmacology studies to support Phase II/III and NDA filings

Experience with large international Phase 3 studies (up to 5400 patients) implementing novel approaches to meet development program goal of accelerated NDA submissions. Participated in sponsor and investigational site inspection readiness activities as part of scheduled and potential regulatory agency inspections

Member of Development Operations leadership team to develop strategy and goals to drive higher capabilities, productivity and quality levels. Participated in R&D Quality and Compliance routine audits to identify process gaps, develop corrective actions plans, and implement training plans

Created a highly motivated teams through effective leadership, coaching and people management ensuring an objective and performance-led management culture.

Christina’s breadth of experience and understanding of clinical research comes from working throughout healthcare and clinical research in academics, medical institutions, local government (public health), and the medical device industry. She is the Director of Clinical Affairs at ReCor Medical, a Palo-Alto based company studying an ultrasound-based renal denervation technology to treat hypertension. She thrives on being challenged, creative and innovative while building highly effective and impactful clinical teams. She enjoys mentoring and leading others positively through her actions and energy.

Areas of Interest: Leadership, Clinical Research, Trial Management, Monitoring, Health Education, Project Management, Lecturer, Epidemiology, Public Health, Certified Clinical Research Associate, Leading remote and in-house teams.

Robert sits on various Finance & Leasing Association (hyperlink) committees as well as being deputy Chairman of the Asset Finance Professionals Association (again hyperlink) which is the UK’s Asset Finance industry charity and is a Founder Fellow of The Leasing Foundation (again hyperlink). Robert has previously sat on the Board of several major UK Charities including the National Autistic Society and Arts for All and is currently a main Patron of The Royal Albert Hall.

Robert is responsible for growing and expanding LTi business throughout the UK, Nordics and Europe.

Gale McCandlish is an experienced Quality Assurance professional with an extensive background in GCP and GLP compliance for both pharmaceutical companies and CROs. In her current role as Associate Director, Vendor Compliance at Gilead Sciences, Ms. McCandlish is accountable for GCP vendor risk management and audit strategy.  During the COVID-19 pandemic, Gale authored a remote audit process to ensure the continuation of vendor audit oversight responsibilities when onsite audits are not feasible.

Gale holds a BS in Biology from Bemidji State University and completed graduate work towards an MS in Biology from The George Washington University

• Formerly Global Head of Asset Management and Remarketing at DLL one of the world’s premier leasing companies.
• Ian brings vast experience of all aspects of asset management and is expert in equipment risk management and development of circular economic models.
• Prior to DLL, Ian worked for Dell Financial Services, CIT and Siemens Financial Services and is highly experienced in all aspects of vendor and direct leasing.
• Ian is an engineer by training as is a graduate of Manchester and Cambridge Universities in the UK.
• He is an industry leader capable of bridging between high level business strategy and the practicalities of systems, risk management, information management, process development, organizational delivery.
• Ian is regularly called on by clients to help develop their systems and technology ecosystems and has also helped several software vendors extend their value propositions.
• Originally a strategic business consultant he regularly supports OEMs and vendor finance companies in developing their business and financing strategies.

. PhD Food Inspection and Technology
. Food Industry | Quality & Food Safety Strategy | Research and Development | Responsible Sourcing | Regenerative Agriculture | Dairy Farming